Policy Reporter
Adil Engineer has amassed extensive experience in the pharmaceutical and healthcare sectors, currently serving as an Associate Product Manager and previously as a Senior Research Analyst and Vendor Coordinator at Policy Reporter by Mercalis since August 2019. Adil's work has involved providing key insights into drug competitiveness in U.S. markets, collaborating on product development projects, and leading interdepartmental research initiatives. Prior experience includes roles as an Alumni Coordinator for UNICEF UBC during the COVID-19 pandemic and various leadership positions within the organization, as well as marketing and research positions at the University of British Columbia. Adil holds a Bachelor of Arts in Political Science with a focus on Law and Society from the University of British Columbia.
This person is not in any offices
Policy Reporter
Policy Reporter by Mercalis is an industry-leading service that provides business intelligence to the medical industry. Our objective is to improve the way the medical industry receives, processes, and acts on healthcare policy developments by providing access to the very latest payer coverage data. Policy Reporter leverages its proprietary software to track medical, diagnostic, and pharmaceutical policy updates as they happen, all across the United States. No other consultancy or company exclusively serves the market access industry the way we do. Our automated, real-time approach to tracking policy changes combined with the depth of our expertise provides our customers with an invaluable market access resource. Subscribers to Policy Reporter Can: • Receive live payer policy alerts. • Track medical policies, pharmacy policies, formularies, billing guidelines, and other key documents. • Access payer policy documents in a central database. • Analyze coverage for their product and competing products through dynamic reporting and analysis tools. • Research key payer data including payer contacts, covered lives, contractual relations, and more to optimize their market access strategy.